Ads
related to: colorectal cancer survival rate
Search results
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
Benzinga via Yahoo Finance· 6 days agoTuesday, the FDA's staff reviewers raised concerns regarding Guardant Health Inc's (NASDAQ:GH)...
Guardant colon cancer test struggles to detect non-cancerous tumors, FDA says
MedTech Dive via Yahoo Finance· 6 days agoEarlier treatment could potentially cure the patient or prolong survival, FDA scientists said in...
Cancer in Canada: Increasing Cases, Decreasing Diagnoses
Medscape· 7 days agoThe numbers of cancer cases and deaths are rising in Canada, even as overall rates of cancer...
Panel recommends blood test to detect colon cancer for FDA approval
UPI· 4 days agocancers, and over a third of those cases are expected to be fatal. May 23 (UPI) -- A panel of U.S....
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 21 hours agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Support Early Detection Technology to Save the Lives of Black Cancer Patients - Los Angeles Sentinel
Los Angeles Sentinel· 5 days agoThe stark reality that Black women are 41% more likely to die from breast cancer than White women is a grim reminder of the systemic inequities that pervade our health care ...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 5 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
MD Anderson Research Highlights: ASCO 2024 Special | Newswise
Newswise· 5 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Blood Test for Colon Cancer Screening May Miss Some Precancers, FDA Staff Says
MedPage Today· 6 days agoFDA reviewers questioned the potential benefits of Guardant Health's blood-based test for colorectal...
... in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to...
ThePress.net· 4 days agoThe updated interim evaluation (data cut-off: August 31, 2023) of 19 enrolled patients in ASP-1929-181 study suggests that the novel treatment approach of ASP-1929 photoimmunotherapy in combination ...
Ads
related to: colorectal cancer survival rate